Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-12-000464
Filing Date
2012-11-19
Accepted
2012-11-19 10:39:47
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plpl_form10q9302012.htm 10-Q 285504
2 EXHIBIT 31 ex31.htm EX-31 11152
3 EXHIBIT 32 ex32.htm EX-32 6914
  Complete submission text file 0001262463-12-000464.txt   1581862

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT plpl-20120930.xml EX-101.INS 90662
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plpl-20120930.xsd EX-101.SCH 20443
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plpl-20120930_cal.xml EX-101.CAL 29349
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plpl-20120930_def.xml EX-101.DEF 32506
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plpl-20120930_lab.xml EX-101.LAB 131145
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plpl-20120930_pre.xml EX-101.PRE 96186
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (425) 466-0212
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

EIN.: 453642179 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51206 | Film No.: 121213473
SIC: 2834 Pharmaceutical Preparations